Lista de obras - Julia Bonastre - Dominio Público Uruguay

A prospective multicenter study on bladder cancer: the COBLAnCE cohort.

artículo científico publicado en 2016

Access to innovation: is there a difference in the use of expensive anticancer drugs between French hospitals?

artículo científico publicado en 2013

Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis.

artículo científico publicado en 2016

Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin.

artículo científico publicado en 2008

Cost effectiveness of modified fractionation radiotherapy versus conventional radiotherapy for unresected non-small-cell lung cancer patients

artículo científico publicado en 2013

Cost effectiveness of molecular profiling for adjuvant decision making in patients with node-negative breast cancer

artículo científico publicado en 2014

Cost of radiofrequency ablation in the treatment of hepatic malignancies

artículo científico publicado en 2007

Cost-effectiveness of intraperitoneal chemohyperthermia in the treatment of peritoneal carcinomatosis from colorectal cancer

artículo científico publicado en 2008

Dead space closure with quilting suture versus conventional closure with drainage for the prevention of seroma after mastectomy for breast cancer (QUISERMAS): protocol for a multicentre randomised controlled trial.

artículo científico publicado en 2016

Difference in Restricted Mean Survival Time for Cost-Effectiveness Analysis Using Individual Patient Data Meta-Analysis: Evidence from a Case Study

artículo científico publicado en 2016

Economic analysis of multinational clinical trials in oncology

artículo científico publicado en 2018

Erratum to: Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis.

artículo científico publicado en 2016

European cost-effectiveness study of uPA/PAI-1 biomarkers to guide adjuvant chemotherapy decisions in breast cancer.

artículo científico publicado en 2016

Impact of Competition Versus Centralisation of Hospital Care on Process Quality: A Multilevel Analysis of Breast Cancer Surgery in France

artículo científico publicado en 2020

Implications of learning effects for hospital costs of new health technologies: the case of intensity modulated radiation therapy

scientific article published on 01 January 2007

Medico-economic evaluation of abciximab

artículo científico publicado en 1999

Metastatic breast cancer: We do need primary cost data ⬇️

artículo científico publicado el 19 de abril de 2012

Quality of Life and Cost-Effectiveness Assessment of Radioiodine Ablation Strategies in Patients With Thyroid Cancer: Results From the Randomized Phase III ESTIMABL Trial

artículo científico publicado en 2015

Reply to V.P. Retèl et al, D. Gauchan et al, and C. Rahilly-Tierney et al.

artículo científico publicado en 2015

Selection of an early biomarker for vascular normalization using dynamic contrast-enhanced ultrasonography to predict outcomes of metastatic patients treated with bevacizumab

artículo científico publicado en 2016

The 5000% case: a glimpse into the financial issue of lung cancer treatment.

artículo científico publicado en 2016

The burden of age-related macular degeneration: results of a cohort study in two French referral centres.

artículo científico publicado en 2003

The challenge of rapid diagnosis in oncology: Diagnostic accuracy and cost analysis of a large-scale one-stop breast clinic

artículo científico publicado en 2016

The cost of molecular-guided therapy in oncology: a prospective cost study alongside the MOSCATO trial.

artículo científico publicado en 2016

The epidemiology, economics and quality of life burden of age-related macular degeneration in France, Germany, Italy and the United Kingdom.

artículo científico publicado en 2002

The impact of research on hospital costs of care: an empirical study

artículo científico publicado en 2010

The rising prevalence of chronic myeloid leukemia in France.

artículo científico publicado en 2018

Use of Low-Thrombin Fibrin Sealant Glue After Axillary Lymphadenectomy for Breast Cancer to Reduce Hospital Length and Seroma.

artículo científico publicado en 2017

Validation of dynamic contrast-enhanced ultrasound in predicting outcomes of antiangiogenic therapy for solid tumors: the French multicenter support for innovative and expensive techniques study

artículo científico publicado en 2014

Variation in rates of breast cancer surgery: A national analysis based on French Hospital Episode Statistics

artículo científico publicado en 2015

[Cost of an intraperitoneal chemohyperthermia (IPCH) related to cytoreductive surgery]

artículo científico publicado en 2005

[Cost of treatment and follow up of breast cancer: a retrospective assessment in a comprehensive cancer centre]

scientific article published on 01 June 2002

[How to measure research emerging from hospitals? The case of French comprehensive cancer centres]

artículo científico publicado en 2006

[Medical-economic models of benign prostatic hypertrophy]

artículo científico publicado en 1998

[The cost of chemotherapy]

scientific article published on 01 November 2003

[uPA/PAI-1, Oncotype DX™, MammaPrint(®). Prognosis and predictive values for clinical utility in breast cancer management]

artículo científico publicado en 2014

uPA/PAI-1, Oncotype DX™, MammaPrint(®). Prognosis and predictive values for clinical utility in breast cancer management

artículo científico publicado en 2015

Lista de obras de Julia Bonastre

A prospective multicenter study on bladder cancer: the COBLAnCE cohort.

Access to innovation: is there a difference in the use of expensive anticancer drugs between French hospitals?

Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis.

Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin.

Cost effectiveness of modified fractionation radiotherapy versus conventional radiotherapy for unresected non-small-cell lung cancer patients

Cost effectiveness of molecular profiling for adjuvant decision making in patients with node-negative breast cancer

Cost of radiofrequency ablation in the treatment of hepatic malignancies

Cost-effectiveness of intraperitoneal chemohyperthermia in the treatment of peritoneal carcinomatosis from colorectal cancer

Dead space closure with quilting suture versus conventional closure with drainage for the prevention of seroma after mastectomy for breast cancer (QUISERMAS): protocol for a multicentre randomised controlled trial.

Difference in Restricted Mean Survival Time for Cost-Effectiveness Analysis Using Individual Patient Data Meta-Analysis: Evidence from a Case Study

Economic analysis of multinational clinical trials in oncology

Erratum to: Bias and precision of methods for estimating the difference in restricted mean survival time from an individual patient data meta-analysis.

European cost-effectiveness study of uPA/PAI-1 biomarkers to guide adjuvant chemotherapy decisions in breast cancer.

Impact of Competition Versus Centralisation of Hospital Care on Process Quality: A Multilevel Analysis of Breast Cancer Surgery in France

Implications of learning effects for hospital costs of new health technologies: the case of intensity modulated radiation therapy

Medico-economic evaluation of abciximab

Metastatic breast cancer: We do need primary cost data ⬇️

Quality of Life and Cost-Effectiveness Assessment of Radioiodine Ablation Strategies in Patients With Thyroid Cancer: Results From the Randomized Phase III ESTIMABL Trial

Reply to V.P. Retèl et al, D. Gauchan et al, and C. Rahilly-Tierney et al.

Selection of an early biomarker for vascular normalization using dynamic contrast-enhanced ultrasonography to predict outcomes of metastatic patients treated with bevacizumab

The 5000% case: a glimpse into the financial issue of lung cancer treatment.

The burden of age-related macular degeneration: results of a cohort study in two French referral centres.

The challenge of rapid diagnosis in oncology: Diagnostic accuracy and cost analysis of a large-scale one-stop breast clinic

The cost of molecular-guided therapy in oncology: a prospective cost study alongside the MOSCATO trial.

The epidemiology, economics and quality of life burden of age-related macular degeneration in France, Germany, Italy and the United Kingdom.

The impact of research on hospital costs of care: an empirical study

The rising prevalence of chronic myeloid leukemia in France.

Use of Low-Thrombin Fibrin Sealant Glue After Axillary Lymphadenectomy for Breast Cancer to Reduce Hospital Length and Seroma.

Validation of dynamic contrast-enhanced ultrasound in predicting outcomes of antiangiogenic therapy for solid tumors: the French multicenter support for innovative and expensive techniques study

Variation in rates of breast cancer surgery: A national analysis based on French Hospital Episode Statistics

[Cost of an intraperitoneal chemohyperthermia (IPCH) related to cytoreductive surgery]

[Cost of treatment and follow up of breast cancer: a retrospective assessment in a comprehensive cancer centre]

[How to measure research emerging from hospitals? The case of French comprehensive cancer centres]

[Medical-economic models of benign prostatic hypertrophy]

[The cost of chemotherapy]

[uPA/PAI-1, Oncotype DX™, MammaPrint(®). Prognosis and predictive values for clinical utility in breast cancer management]

uPA/PAI-1, Oncotype DX™, MammaPrint(®). Prognosis and predictive values for clinical utility in breast cancer management